Literature DB >> 22872297

A randomized, double-blind, placebo-controlled study of single dose rituximab as induction in renal transplantation: a 3-year follow-up.

Gunnar Tydén, Henrik Ekberg, Gunnar Tufveson, Lars Mjörnstedt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22872297     DOI: 10.1097/01.tp.0000418580.88642.e1

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  16 in total

Review 1.  Effect of Immunosuppressive Drugs on Humoral Allosensitization after Kidney Transplant.

Authors:  Olivier Thaunat; Alice Koenig; Claire Leibler; Philippe Grimbert
Journal:  J Am Soc Nephrol       Date:  2016-02-12       Impact factor: 10.121

2.  Transplantation: rituximab induction only for sensitized kidney recipients?

Authors:  Christian Morath; Caner Süsal
Journal:  Nat Rev Nephrol       Date:  2013-10-22       Impact factor: 28.314

3.  B cell modulation in transplantation.

Authors:  M R Clatworthy
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

Review 4.  B cells in transplant tolerance and rejection: friends or foes?

Authors:  Robin Schmitz; Zachary W Fitch; Paul M Schroder; Ashley Y Choi; Annette M Jackson; Stuart J Knechtle; Jean Kwun
Journal:  Transpl Int       Date:  2020-01       Impact factor: 3.782

Review 5.  Strategies to overcome the ABO barrier in kidney transplantation.

Authors:  Georg A Böhmig; Andreas M Farkas; Farsad Eskandary; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2015-09-01       Impact factor: 28.314

6.  IL-10 from marginal zone precursor B cells controls the differentiation of Th17, Tfh and Tfr cells in transplantation tolerance.

Authors:  Girdhari Lal; Neeraja Kulkarni; Yumi Nakayama; Amit K Singh; Apoorva Sethi; Bryna E Burrell; C Colin Brinkman; Daiki Iwami; Tianshu Zhang; Thomas Hehlgans; Jonathan S Bromberg
Journal:  Immunol Lett       Date:  2016-01-06       Impact factor: 3.685

7.  Managing transplant rejection in the elderly: the benefits of less aggressive immunosuppressive regimens.

Authors:  Kristian Heldal; Karsten Midtvedt
Journal:  Drugs Aging       Date:  2013-07       Impact factor: 3.923

8.  Inflammation Causes Resistance to Anti-CD20-Mediated B Cell Depletion.

Authors:  L H Laws; C E Parker; G Cherala; Y Koguchi; A Waisman; M K Slifka; M H Oberbarnscheidt; J S Obhrai; M Y Yeung; L V Riella
Journal:  Am J Transplant       Date:  2016-07-12       Impact factor: 8.086

Review 9.  HLA sensitisation: can it be prevented?

Authors:  Lesley Rees; Jon Jin Kim
Journal:  Pediatr Nephrol       Date:  2014-07-26       Impact factor: 3.714

Review 10.  Monoclonal antibody therapy and renal transplantation: focus on adverse effects.

Authors:  Gianluigi Zaza; Paola Tomei; Simona Granata; Luigino Boschiero; Antonio Lupo
Journal:  Toxins (Basel)       Date:  2014-02-28       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.